The Business of Cannabis: Berlin Executive Summit is set to host over 150 top executives, policymakers, and thought leaders at Palisa.de on 26 November, as Germany navigates a crucial phase in its cannabis industry development. This exclusive half-day summit will explore the varied commercial opportunities within the new regulatory framework and deep dive into the challenges they present.
Berlin has every chance of becoming the future European capital of cannabis, positioning itself at the heart of the continent’s cannabis revolution. Combined sales of CBD, medical and adult-use cannabis in Germany are forecast to reach €1.7 billion by 2028, according to new data published by Prohibition Partners in The German Cannabis Report.
As Germany moves toward full cannabis legalisation, this summit will address vital industry questions such as the opportunities within the new association model, potential future market consolidation, and the medical cannabis market’s future import and export possibilities.
Vasili Franco, speaker at the summit and drug policy spokesperson for Alliance 90/the Greens in the Berlin House of Representatives said: “The new cannabis legislation is a turning point in German drug policy. It’s about accepting cannabis consumption as a reality and driving forward effective regulation. However, it is also just a first step on the path to true legalisation.”
Larissa Mößmer, Lawyer at Osborn Clark added “The German / Berlin cannabis sector is in a transformative phase, with recent legislation efforts creating both opportunities and regulatory challenges. While the market shows significant growth potential, clarity in legislation and infrastructure development will be key to its success.”
Vladimir Kofcegarski, Chief Sales Officer at PHCANN International, headline sponsors of the summit, said: “Germany’s recent legislation marks a new era in the cannabis industry in Europe. This is a pivotal opportunity for innovation, economic growth and responsible regulation for all of us in the industry. With Germany as the main driver of cannabis sector de-stigmatisation in Europe, we now have the tools and responsibility to build foundations that will foster sustainable practices and standards.”
Agenda Highlights for 26th November:
- Association Model: Exploring the commercial opportunities in cannabis associations.
- Pillar 2 and 2025 Elections: Understanding the long-term political outlook and possibility of Pillar 2 not coming into fruition.
- Medical Market Boom: Projecting the future of domestic cannabis production.
- Market Consolidation: Analysing possible mergers and acquisitions in the German cannabis market.
This summit will feature six panels featuring established industry experts, keynote presentations, and interactive discussions to foster actionable insights and connections. Participants will have access to curated networking opportunities with leading C-suite executives, government representatives, and market pioneers, positioning them for success in Germany’s rapidly evolving cannabis industry.
For partnership opportunities and last remaining tickets to join us on 26th November, visit www.cannabisberlin.live (only 50 available for purchase)
For more information and media passes, please contact Mike Hoban – michael@prohibitionpartners.com.
